BD Venflon Cannula and Catheter Range

BD Venflon Cannula and Catheter Range

Becton Dickinson

Injection & Infusion Devices
  • CE marked medical device (CE 2797) for use in the European Economic Area, as indicated by BD.
  • Manufactured under BD quality management system in accordance with applicable medical device regulations (e.g. ISO 13485).
  • Designed to comply with occupational safety requirements for needlestick injury reduction where applicable.
Peripheral IV Cannula / Safety IV Catheter

Description

BD Venflon Pro Safety™ 22G x 25 mm Blue is a needle-protected peripheral intravenous (IV) cannula designed for safe venous access and infusion therapy. This ported, passive safety IV catheter combines a BD Vialon™ softening catheter with an integrated injection port and automated needle protection mechanism to help minimise the risk of blood exposure and needlestick injuries. The 22-gauge, 25 mm blue cannula is suitable for a wide range of adult and paediatric IV therapies where moderate flow rates are required, offering reliable vessel access, patient comfort and extended dwell times when used according to clinical guidelines.

Bnefits

  • Ported, passive safety IV cannula designed to reduce needlestick injuries via automatic needle tip shielding on withdrawal.
  • BD Vialon™ catheter material softens in the vein, supporting longer dwell times and reducing the risk of mechanical phlebitis.
  • Back-cut needle bevel and sharp stainless steel needle designed for optimal skin and vein penetration and smoother insertion.
  • Flexible wings and integrated extension help stabilise the catheter and improve patient comfort.
  • Integrated injection port with ‘snap’ cap allows needle-free administration of bolus medications during infusion.
  • Removable vent cap helps reduce blood exposure and supports controlled priming and connection.
  • 22G x 25 mm size provides a balance between adequate flow rate and patient comfort, suitable for many routine infusions.
  • Individually sterile blister packs support infection prevention and single-use safety.
  • CE-marked medical device manufactured under BD’s quality management system.

Indications

  • Peripheral intravenous cannulation for administration of IV fluids and medications.
  • Peripheral infusion of compatible solutions, including rehydration fluids and parenteral therapies as per local protocols.
  • Blood transfusion and blood sampling via a peripheral venous route when clinically appropriate.
  • Short- to medium-term peripheral IV access in hospital, outpatient and day-case settings, including oncology and general medical/surgical wards.

Composition

  • Catheter: BD Vialon™ softening polyurethane catheter, 22G, 0.9 mm outer diameter, 25 mm length.
  • Needle: stainless steel back-cut needle with bevel designed for optimal penetration.
  • Hub and wings: polymer hub with large, soft stabilisation wings for secure fixation.
  • Integrated injection port with ‘snap’ cap for needle-free access.
  • Removable white vent cap to aid priming and reduce blood exposure.
  • Passive safety needle protection mechanism that automatically shields the needle tip when withdrawn.

Formulation

  • Single-use, sterile peripheral IV cannula with integrated port and passive needle safety mechanism, 22G x 25 mm (Blue), for human use.

Packaging

  • Box of 50 BD Venflon Pro Safety™ 22G x 25 mm Blue IV cannulae.
  • Each cannula supplied individually sterile in a blister pack.
  • Packaged for single use only; do not resterilise or reuse.
  • Outer carton labelled with BD product code (393222), gauge, length, colour code and lot/expiry information.

Usage

  • Verify integrity of the sterile blister pack, product code, gauge and expiry date before use; do not use if damaged or expired.
  • Prepare the insertion site following local aseptic technique and infection prevention policies.
  • Remove the cannula from the blister, ensuring the safety mechanism is in the ready (non-activated) position.
  • Stabilise the chosen peripheral vein and insert the needle–catheter assembly bevel up at the appropriate angle.
  • Confirm venous entry by flashback in the chamber, then advance the catheter into the vein while holding the needle steady.
  • Once the catheter is fully advanced, withdraw the needle to activate the passive safety mechanism, ensuring the needle tip is fully shielded.
  • Connect the catheter hub to IV line, extension set or cap according to local protocols and secure with appropriate dressing and fixation.
  • Use the integrated injection port with the ‘snap’ cap for needle-free bolus medication administration as required, following compatibility guidelines.
  • Monitor the insertion site regularly for signs of phlebitis, infiltration, leakage or infection and remove the cannula promptly if complications occur or when IV therapy is no longer required.
  • Dispose of the used device in an approved sharps or clinical waste container in accordance with local regulations.

Contraindications

  • Do not use in patients with known hypersensitivity or allergy to device materials (e.g. polyurethane, stainless steel or component plastics).
  • Avoid insertion into limbs or sites with existing infection, thrombosis, significant oedema, burns or compromised circulation unless clinically justified.
  • Avoid veins distal to an area of thrombophlebitis or in the same limb as an existing arteriovenous fistula or vascular access device unless directed by a specialist.
  • Not intended for arterial cannulation or for intrathecal, epidural or central venous access.
  • Do not reuse or resterilise; single-use only.

Adverse Effects

  • Local pain, discomfort or bruising at the insertion site.
  • Mechanical phlebitis or chemical phlebitis of the cannulated vein.
  • Infiltration or extravasation of infused solutions into surrounding tissues.
  • Local infection or, rarely, systemic infection or sepsis if aseptic technique is not maintained.
  • Hematoma, bleeding or leakage at the insertion or port site.
  • Thrombosis or occlusion of the cannulated vein.
  • Allergic or hypersensitivity reactions to device materials in susceptible individuals.
  • Potential complications associated with peripheral IV devices such as catheter dislodgement or breakage if misused.

Storage Conditions

  • Store in a clean, dry environment at controlled room temperature as indicated on the packaging.
  • Keep away from direct sunlight, excessive heat or moisture.
  • Store in original packaging until point of use to maintain sterility.
  • Do not use after the expiration date printed on the packaging.
  • Do not use if the sterile blister pack is open, damaged or contaminated.

Duration

Intended for short- to medium-term peripheral IV use; catheter dwell time should be determined by clinical judgement, local protocols and patient condition, as BD does not specify a fixed maximum in situ duration.

Onset

Immediate upon successful venous cannulation and initiation of prescribed intravenous therapy.

Browse more Injection & Infusion Devices

Top Treatments

Top Cities in the UK